Literature DB >> 18607531

The structure-activity relationship between oxycoumarin derivatives showing inhibitory effects on iNOS in mouse macrophage RAW264.7 cells.

Tomonori Nakamura1, Naoko Kodama, Manabu Oda, Shizuko Tsuchiya, Yu Arai, Takuya Kumamoto, Tsutomu Ishikawa, Koichi Ueno, Shingo Yano.   

Abstract

We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (iNOS) induced by lipopolysaccharide. The protein expression of iNOS was screened by Western blot analysis, and four 5,7-dimethoxycoumarins were selected as potent inhibitors of iNOS expression. In terms of structural specificity, the methoxyl group on C-5 and C-7 and the short alkyl chain (1-5 carbons) on C-6 may be essential for the potent activities. These compounds also showed inhibitory effects on nitric oxide generation and mRNA expression of inflammatory mediators, namely, iNOS and COX-2. Interestingly, the inhibitory effect on mRNA expression was specific for iNOS and was not detected for neuronal NOS. It is expected that these compounds will show anti-inflammatory activities via inhibition of the expressions of iNOS and COX-2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18607531     DOI: 10.1007/s11418-008-0268-6

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  15 in total

1.  Synthesis and biological evaluation of novel angularly fused polycyclic coumarins.

Authors:  Imtyaz A Khan; Manohar V Kulkarni; M Gopal; M S Shahabuddin; Chung-Ming Sun
Journal:  Bioorg Med Chem Lett       Date:  2005-08-01       Impact factor: 2.823

Review 2.  Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator?

Authors:  H Kolb; V Kolb-Bachofen
Journal:  Immunol Today       Date:  1998-12

3.  Inducible nitric oxide synthase inhibitors of Chinese herbs. Part 2: naturally occurring furanocoumarins.

Authors:  C C Wang; J E Lai; L G Chen; K Y Yen; L L Yang
Journal:  Bioorg Med Chem       Date:  2000-12       Impact factor: 3.641

4.  Immunological and antitumor effects of coumarin and some derivatives.

Authors:  F Rosskopf; J Kraus; G Franz
Journal:  Pharmazie       Date:  1992-02       Impact factor: 1.267

Review 5.  Nitric oxide and inflammatory arthritides.

Authors:  N Miyasaka; Y Hirata
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

6.  A new lignan from Balanophora abbreviata and inhibition of lipopolysaccharide (LPS)-induced inducible nitric oxide synthase (iNOS) expression.

Authors:  Akihiro Hosokawa; Megumi Sumino; Tomonori Nakamura; Shingo Yano; Toshikazu Sekine; Nijsiri Ruangrungsi; Kazuko Watanabe; Fumio Ikegami
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-10       Impact factor: 1.645

7.  Sesquiterpene coumarins from Ferula fukanensis and nitric oxide production inhibitory effects.

Authors:  Tsunetake Motai; Susumu Kitanaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-10       Impact factor: 1.645

8.  Biochemical characterisation of elsamicin and other coumarin-related antitumour agents as potent inhibitors of human topoisomerase II.

Authors:  A Lorico; B H Long
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

9.  Anti-proliferative and antioxidant activities of Saposhnikovia divaricata.

Authors:  Joseph Tai; Susan Cheung
Journal:  Oncol Rep       Date:  2007-07       Impact factor: 3.906

10.  Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice.

Authors:  Alexander Kaminski; Christiane Backhaus Pohl; Christoph Sponholz; Nan Ma; Christof Stamm; Brigitte Vollmar; Gustav Steinhoff
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

View more
  6 in total

1.  Toddaculin, Isolated from of Toddalia asiatica (L.) Lam., Inhibited Osteoclastogenesis in RAW 264 Cells and Enhanced Osteoblastogenesis in MC3T3-E1 Cells.

Authors:  Akio Watanabe; Momochika Kumagai; Takashi Mishima; Junya Ito; Yurika Otoki; Teppei Harada; Tsuyoshi Kato; Mikihiko Yoshida; Misora Suzuki; Izumi Yoshida; Kazuhiro Fujita; Masatoshi Watai; Kiyotaka Nakagawa; Teruo Miyazawa
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

2.  LC-MS/MS determination and pharmacokinetic study of columbianadin in rat plasma after intravenous administration of pure columbianadin.

Authors:  Yan-Xu Chang; Chun-Peng Wang; Jin Li; Yang Bai; Qian Luo; Jun He; Bing Lu; Tao Wang; Bo-Li Zhang; Xiu-Mei Gao
Journal:  Chem Cent J       Date:  2014-11-21       Impact factor: 4.215

3.  Promising Compounds From Murraya exotica for Cancer Metastasis Chemoprevention.

Authors:  Su-Dan He; Xing-Tian Yang; Cui-Cui Yan; Zhou Jiang; Su-Hong Yu; Yu-Yang Zhou; Lee Jia
Journal:  Integr Cancer Ther       Date:  2016-11-21       Impact factor: 3.279

4.  3D-QSAR and Molecular Docking Studies on the TcPMCA1-Mediated Detoxification of Scopoletin and Coumarin Derivatives.

Authors:  Qiu-Li Hou; Jin-Xiang Luo; Bing-Chuan Zhang; Gao-Fei Jiang; Wei Ding; Yong-Qiang Zhang
Journal:  Int J Mol Sci       Date:  2017-06-27       Impact factor: 5.923

Review 5.  Isofraxidin: Synthesis, Biosynthesis, Isolation, Pharmacokinetic and Pharmacological Properties.

Authors:  Mohammad Bagher Majnooni; Sajad Fakhri; Yalda Shokoohinia; Mahdi Mojarrab; Sara Kazemi-Afrakoti; Mohammad Hosein Farzaei
Journal:  Molecules       Date:  2020-04-27       Impact factor: 4.411

6.  Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation.

Authors:  Wen Yan; Chunge Zheng; Jiayang He; Wenjie Zhang; Xin-An Huang; Xiong Li; Yutao Wang; Xinhua Wang
Journal:  Int J Mol Med       Date:  2018-09-07       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.